SuppreMol GmbH is now a part of Baxalta

Since March 2015, SuppreMol GmbH is part of Baxalta. For more information, please visit or Thank you.


tl_files/Baxalta Logo Color RGB.jpg

Baxalta is a leading biopharmaceutical company advancing innovative therapies in hematology, immunology, and oncology. See more at:


tl_files/SuppreMol Logo_neu 2015.jpg

The SuppreMol site in Martinsried, located in the southwest of the Bavarian capital Munich (Germany) brings a strong immunological heritage with a vast knowledge of Fc-receptors to the R&D of Baxalta.

A team of 24 highly motivated scientist and clinical experts (including administration and support) focusses on the biology of human Fc-receptors especially soluble FcγRIIb receptors. These receptors play a pivotal role in human immunity and autoimmune diseases.

In addition to SM101 (lead product, recombinant soluble human FcγRIIb), SuppreMol also works on anti-FcγRIIb antibodies, for the treatment of autoimmune diseases (SM2x1 project) and allergic reactions (SM301 project).

SuppreMol GmbH
Am Klopferspitz 19a
82152 Martinsried / Munich
Tel: +49-89-30 90 50 680